Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Liver Diseases

  Free Subscription


Articles published in J Clin Oncol

Retrieve available abstracts of 34 articles:
HTML format
Text format



Single Articles


    April 2017
  1. GROOT KOERKAMP B, Sadot E, Kemeny NE, Gonen M, et al
    Perioperative Hepatic Arterial Infusion Pump Chemotherapy Is Associated With Longer Survival After Resection of Colorectal Liver Metastases: A Propensity Score Analysis.
    J Clin Oncol. 2017 Apr 20:JCO2016718346. doi: 10.1200/JCO.2016.71.8346.
    PubMed     Text format     Abstract available


  2. BRAILLON A
    Recurrence in Early-Stage Hepatocellular Carcinoma: CpG Methylation and Smoking.
    J Clin Oncol. 2017 Apr 11:JCO2017723932. doi: 10.1200/JCO.2017.72.3932.
    PubMed     Text format    


    January 2017
  3. ZHONG JH, Tan JT, Li LQ, Wu WS, et al
    Transarterial Embolization With or Without Chemotherapy: What Should Be the Indication for Patients With Hepatocellular Carcinoma?
    J Clin Oncol. 2017;35:257-258.
    PubMed     Text format    


  4. BOULIN M, Guiu B
    Chemoembolization or Bland Embolization for Hepatocellular Carcinoma: The Question Is Still Unanswered.
    J Clin Oncol. 2017;35:256-257.
    PubMed     Text format    


  5. BRAILLON A
    Delusional Beliefs and Hepatocellular Carcinoma.
    J Clin Oncol. 2017;35:256.
    PubMed     Text format    


  6. QIU J, Peng B, Tang Y, Qian Y, et al
    CpG Methylation Signature Predicts Recurrence in Early-Stage Hepatocellular Carcinoma: Results From a Multicenter Study.
    J Clin Oncol. 2017 Jan 9:JCO2016682153.
    PubMed     Text format     Abstract available


  7. JACKSON R, Psarelli EE, Berhane S, Khan H, et al
    Impact of Viral Status on Survival in Patients Receiving Sorafenib for Advanced Hepatocellular Cancer: A Meta-Analysis of Randomized Phase III Trials.
    J Clin Oncol. 2017 Jan 3:JCO2016695197.
    PubMed     Text format     Abstract available


  8. DONG R, Zheng S, Dong K
    Distinguishing Among Pediatric Hepatoblastomas, Transitional Liver Cell Tumors, and Hepatocellular Carcinomas and Using Appropriate Chemotherapy Regimens.
    J Clin Oncol. 2017;35:115-116.
    PubMed     Text format    


    December 2016
  9. CLOUGHESY T, Finocchiaro G, Belda-Iniesta C, Recht L, et al
    Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of Onartuzumab Plus Bevacizumab Versus Placebo Plus Bevacizumab in Patients With Recurrent Glioblastoma: Efficacy, Safety, and Hepatocyte Growth Factor and O6-Methylguanine-DNA M
    J Clin Oncol. 2016 Dec 5:JCO2015647685.
    PubMed     Text format     Abstract available


    June 2016
  10. DE BARI B, Ozsahin M, Bize P, Boussaha T, et al
    Can Stereotactic Body Radiotherapy Really Be Considered the Preferred Treatment in Large Hepatocellular Carcinoma?
    J Clin Oncol. 2016 Jun 20. pii: JCO667196.
    PubMed     Text format    


  11. YANG JF, Lo CH, Huang WY
    Is Stereotactic Body Radiotherapy Better Than Radiofrequency Ablation for the Treatment of Hepatocellular Carcinoma?
    J Clin Oncol. 2016 Jun 20. pii: JCO664458.
    PubMed     Text format    


    April 2016
  12. PETRICK JL, Kelly SP, Altekruse SF, McGlynn KA, et al
    Future of Hepatocellular Carcinoma Incidence in the United States Forecast Through 2030.
    J Clin Oncol. 2016 Apr 4. pii: JCO647412.
    PubMed     Text format     Abstract available


    March 2016
  13. DAL PRA A, Berlin A, Kumareswaran R, Schattner AJ, et al
    Liver Failure After Abdominal Irradiation: Identifying the Right Suspects.
    J Clin Oncol. 2016;34:e80-3.
    PubMed     Text format    


  14. AKTHAR AS, Golden DW, Nanda R, Sharma MR, et al
    Early and Severe Radiation Esophagitis Associated With Concurrent Sirolimus.
    J Clin Oncol. 2016;34:e73-5.
    PubMed     Text format    


    February 2016
  15. SADOWSKI SM, Neychev V, Millo C, Shih J, et al
    Prospective Study of 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography for Detecting Gastro-Entero-Pancreatic Neuroendocrine Tumors and Unknown Primary Sites.
    J Clin Oncol. 2016;34:588-96.
    PubMed     Text format     Abstract available


  16. BROWN KT, Do RK, Gonen M, Covey AM, et al
    Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres Alone.
    J Clin Oncol. 2016 Feb 1. pii: JCO640821.
    PubMed     Text format     Abstract available


    January 2016
  17. MURAWSKI M, Weeda VB, Maibach R, Morland B, et al
    Hepatocellular Carcinoma in Children: Does Modified Platinum- and Doxorubicin-Based Chemotherapy Increase Tumor Resectability and Change Outcome? Lessons Learned From the SIOPEL 2 and 3 Studies.
    J Clin Oncol. 2016 Jan 25. pii: JCO602250.
    PubMed     Text format     Abstract available


  18. FORCE J, Saxena R, Schneider BP, Storniolo AM, et al
    Nodular Regenerative Hyperplasia After Treatment With Trastuzumab Emtansine.
    J Clin Oncol. 2016;34:e9-12.
    PubMed     Text format    


  19. BARNEA D, Abou-Alfa GK, Bromberg J, D'Angelica MI, et al
    Hepatic adenoma among adult survivors of childhood cancer.
    J Clin Oncol. 2016;34.
    PubMed     Text format     Abstract available


    December 2015
  20. BARRY A, Knox JJ, Wei AC, Dawson LA, et al
    Can Stereotactic Body Radiotherapy Effectively Treat Hepatocellular Carcinoma?
    J Clin Oncol. 2015 Dec 23. pii: JCO648097.
    PubMed     Text format     Abstract available


  21. HONG TS, Wo JY, Yeap BY, Ben-Josef E, et al
    Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
    J Clin Oncol. 2015 Dec 14. pii: JCO642710.
    PubMed     Text format     Abstract available


  22. HURWITZ HI, Uppal N, Wagner SA, Bendell JC, et al
    Randomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic Cancer for Whom Therapy With Gemcitabine Has Failed.
    J Clin Oncol. 2015;33:4039-47.
    PubMed     Text format     Abstract available


    November 2015
  23. WAHL DR, Stenmark MH, Tao Y, Pollom EL, et al
    Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma.
    J Clin Oncol. 2015 Nov 30. pii: JCO614925.
    PubMed     Text format     Abstract available


  24. GRAZIANO P, de Marinis F, Gori B, Gasbarra R, et al
    EGFR-Driven Behavior and Intrapatient T790M Mutation Heterogeneity of Non-Small-Cell Carcinoma With Squamous Histology.
    J Clin Oncol. 2015;33:e115-8.
    PubMed     Text format    


    October 2015
  25. TAO R, Krishnan S, Bhosale PR, Javle MM, et al
    Ablative Radiotherapy Doses Lead to a Substantial Prolongation of Survival in Patients With Inoperable Intrahepatic Cholangiocarcinoma: A Retrospective Dose Response Analysis.
    J Clin Oncol. 2015 Oct 26. pii: JCO.2015.61.3778.
    PubMed     Text format     Abstract available


  26. NEGRI FV, Porta C
    Urea-Based Cream to Prevent Sorafenib-Induced Hand-and-Foot Skin Reaction: Which Evidence?
    J Clin Oncol. 2015;33:3219-20.
    PubMed     Text format    


  27. YE SL
    Reply to F.V. Negri et al.
    J Clin Oncol. 2015;33:3220-1.
    PubMed     Text format    


    August 2015
  28. CAINAP C, McKee MD, Ricker JL
    Reply to M. Bouattour et al.
    J Clin Oncol. 2015;33:2486.
    PubMed     Text format    


    July 2015
  29. PRIMROSE JN, Cunningham D, Garden OJ, Maughan TS, et al
    Cetuximab Is Contraindicated in the Perioperative Treatment of Colorectal Liver Metastases.
    J Clin Oncol. 2015;33:2405-6.
    PubMed     Text format    


  30. NORDLINGER BM, Poston GJ, Goldberg RM
    Reply to J.N. Primrose et al and C.-H. Kohne.
    J Clin Oncol. 2015;33:2408-9.
    PubMed     Text format    


    June 2015
  31. BOUATTOUR M, Rousseau B, Wassermann J, Payance A, et al
    Negative Trials for Foreseeable Safety Reasons in Advanced Hepatocellular Carcinoma: How Long Are We Going to Take Lightly Pharmacokinetics of Tyrosine Kinase Inhibitors?
    J Clin Oncol. 2015 Jun 1. pii: JCO.2014.60.6954.
    PubMed     Text format    


  32. KOHNE CH
    Is Progression-Free Survival the Right End Point in Trials of Patients With Clearly Resectable, Borderline Resectable, and Unresectable Liver-Limited Colorectal Cancer?
    J Clin Oncol. 2015 Jun 1. pii: JCO.2014.60.7044.
    PubMed     Text format    


    May 2015
  33. KULKE MH
    Sequencing and combining systemic therapies for pancreatic neuroendocrine tumors.
    J Clin Oncol. 2015;33:1534-8.
    PubMed     Text format    


    September 2014
  34. HARDING DJ, MacQuillan G, Howman R, de Boer B, et al
    Successful Use of Dasatinib After Liver Transplantation for Imatinib-Induced Fulminant Liver Failure in Chronic Myeloid Leukemia.
    J Clin Oncol. 2014 Sep 29. pii: JCO.2013.50.1320.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: